Skip to main content

Table 3 Pharmacotherapy after the event

From: Lifestyle behaviours in patients with established cardiovascular diseases: a European observational study

 

Men

(n = 608)

Women

(n = 294)

p-value

Betablockers, n (%)

368 (60.53%)

155 (52.72%)

0.026

ACEi/ARBs, n (%)

450 (74.01%)

216 (73.47%)

0.862

Statins, n (%)

544 (89.47%)

241 (81.97%)

0.002

Antiplatelet, n (%)

530 (87.17%)

236 (80.27%)

0.007

Anticoagulants, n (%)

58 (9.54%)

53 (18.03%)

< 0.001

  1. ACEi Angiotensin-converting-enzyme inhibitor, ARBs Angiotensin II receptor blockers